Announcements Trials
Browse Landscape

Status

Completed 3Unknown 1

Sponsor Class

OTHER 10INDUSTRY 4NIH 2

Study Type

Observational 4

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 468Neoplasms 316Carcinoma, Non-Small-Cell Lung 269Prostatic Neoplasms 215Colorectal Neoplasms 208Lung Neoplasms 178Multiple Myeloma 123Melanoma 110Carcinoma, Renal Cell 107Ovarian Neoplasms 94Carcinoma, Hepatocellular 78Pancreatic Neoplasms 69Urinary Bladder Neoplasms 65Stomach Neoplasms 64Neoplasm Metastasis 64Leukemia, Lymphocytic, Chronic, B-Cell 62Colonic Neoplasms 60Leukemia, Myeloid, Acute 53Uterine Cervical Neoplasms 50Recurrence 49Liver Neoplasms 46Lymphoma, Follicular 45Lymphoma 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Esophageal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Large B-Cell, Diffuse 35Hematologic Neoplasms 35Head and Neck Neoplasms 35Lymphoma, Non-Hodgkin 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Dysplastic Nevus Syndrome × Clear all
NCT04368247 2025-08-07

Skin Fluorescent Imaging (SFI) System in Patients With Nevi

Orlucent, Inc

Completed
300 enrolled

Carcinoma in Situ, Dysplastic Nevus Syndrome, Nevus

NCT06246903 2024-02-07

INTER-PATHOLOGIST READER STUDY

Orlucent, Inc

Unknown
500 enrolled

Dysplastic Nevus Syndrome

NCT03535077 2024-01-10

Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)

Orlucent, Inc

Completed
186 enrolled
Dermatologic

Dysplastic Nevus Syndrome, Melanoma, Nevus

NCT03693378 2022-03-31

A Study of IMMrayâ„¢ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Immunovia, Inc.

Completed
1,349 enrolled
Gastrointestinal

Pancreatic carcinoma, familial, Dysplastic Nevus Syndrome, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡